Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

A. Shapira, Y.D. Livney, H.J. Broxterman, Y.G. Assaraf

Research output: Contribution to journal › Article › Academic › peer-review

Cite this

@article{995cb07dec444010b77888385e4c9a2e,

title = "Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance",

author = "A. Shapira and Y.D. Livney and H.J. Broxterman and Y.G. Assaraf",

year = "2011",

doi = "10.1016/j.drup.2011.01.003",

language = "Undefined/Unknown",

volume = "14",

pages = "150--163",

journal = "Drug Resistance Updates",

issn = "1368-7646",

publisher = "Churchill Livingstone",

number = "3",

}

TY - JOUR

T1 - Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

AU - Shapira, A.

AU - Livney, Y.D.

AU - Broxterman, H.J.

AU - Assaraf, Y.G.

PY - 2011

Y1 - 2011

U2 - 10.1016/j.drup.2011.01.003

DO - 10.1016/j.drup.2011.01.003

M3 - Article

C2 - 21330184

VL - 14

SP - 150

EP - 163

JO - Drug Resistance Updates

JF - Drug Resistance Updates

SN - 1368-7646

IS - 3

ER -